Skip to content

Press Needle Intervention for Postoperative Fatigue in Gastric Cancer Patients: A Randomized Controlled Trial

Identification of Core Symptoms in Postoperative Gastric Cancer Patients Based on Network Analysis and Application of Press-Needle Intervention Protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001517
Enrollment
Unknown
Registered
2026-06-20
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

Experimental group :: --- **Selection of acupoints and press-needle intervention** Sterile, disposable press needles (manufacturer: Hangzhou Yuanli Medical
medical device registration number: 20140021
specifications: 0.2×0.9mm short needle, 0.2×1.2mm medium-length needle, 0.2×2mm long needle) were selected. Appropriate needle specifications were chosen based on the patient's body size, regional ana

Sponsors

Zhejiang Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Age = 18 years; (2) Meet the diagnostic criteria for gastric cancer and undergo radical resection surgery for the first time; (3) Conscious, with good understanding and communication skills; (4) Vital signs are stable and able to cooperate with assessment; (5) Voluntarily participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Cognitive impairment or mental disorders; (2) Tumor metastasis to the central nervous system; (3) Severe skin diseases or allergic diseases, or having a bleeding tendency (platelet count < 50 × 10*9/L); (4) Critically ill condition accompanied by severe diseases of the brain, lung, heart, kidney, or other vital organs; (5) Presence of severe fatigue (MDASI fatigue item score = 7) or severe debilitation status before surgery; (6) Simultaneous participation in other interventional clinical trials; (7) Patients who are transferred to another department or hospital, or discharged against medical advice during treatment.

Design outcomes

Primary

MeasureTime frame
Total score of the Revised Piper Fatigue Scale (PFS-R) on postoperative day 7;

Secondary

MeasureTime frame
M.D.Anderson Symptom Inventory Gastroin testinal Cancer Module,MSASI GI;

Countries

china

Contacts

Public ContactJiaoyu Ge

Zhejiang Cancer Hospital

gejiaoyu1987@126.com13588416473

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026